Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

Bruce D. Cheson, John C. Byrd, Kanti R. Rai, Neil Elliot Kay, Susan M. O'Brien, Ian W. Flinn, Adrian Wiestner, Thomas J. Kipps

Research output: Contribution to journalArticle

134 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2820-2822
Number of pages3
JournalJournal of Clinical Oncology
Volume30
Issue number23
DOIs
StatePublished - 2012

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Protein Kinase Inhibitors
Antineoplastic Agents

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cheson, B. D., Byrd, J. C., Rai, K. R., Kay, N. E., O'Brien, S. M., Flinn, I. W., ... Kipps, T. J. (2012). Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. Journal of Clinical Oncology, 30(23), 2820-2822. https://doi.org/10.1200/JCO.2012.43.3748

Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. / Cheson, Bruce D.; Byrd, John C.; Rai, Kanti R.; Kay, Neil Elliot; O'Brien, Susan M.; Flinn, Ian W.; Wiestner, Adrian; Kipps, Thomas J.

In: Journal of Clinical Oncology, Vol. 30, No. 23, 2012, p. 2820-2822.

Research output: Contribution to journalArticle

Cheson, BD, Byrd, JC, Rai, KR, Kay, NE, O'Brien, SM, Flinn, IW, Wiestner, A & Kipps, TJ 2012, 'Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia', Journal of Clinical Oncology, vol. 30, no. 23, pp. 2820-2822. https://doi.org/10.1200/JCO.2012.43.3748
Cheson, Bruce D. ; Byrd, John C. ; Rai, Kanti R. ; Kay, Neil Elliot ; O'Brien, Susan M. ; Flinn, Ian W. ; Wiestner, Adrian ; Kipps, Thomas J. / Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 23. pp. 2820-2822.
@article{97b75337845b45ddb0aaff39a13d25a4,
title = "Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia",
author = "Cheson, {Bruce D.} and Byrd, {John C.} and Rai, {Kanti R.} and Kay, {Neil Elliot} and O'Brien, {Susan M.} and Flinn, {Ian W.} and Adrian Wiestner and Kipps, {Thomas J.}",
year = "2012",
doi = "10.1200/JCO.2012.43.3748",
language = "English (US)",
volume = "30",
pages = "2820--2822",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "23",

}

TY - JOUR

T1 - Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

AU - Cheson, Bruce D.

AU - Byrd, John C.

AU - Rai, Kanti R.

AU - Kay, Neil Elliot

AU - O'Brien, Susan M.

AU - Flinn, Ian W.

AU - Wiestner, Adrian

AU - Kipps, Thomas J.

PY - 2012

Y1 - 2012

UR - http://www.scopus.com/inward/record.url?scp=84865082196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865082196&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.43.3748

DO - 10.1200/JCO.2012.43.3748

M3 - Article

C2 - 22778323

AN - SCOPUS:84865082196

VL - 30

SP - 2820

EP - 2822

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 23

ER -